Article Details

Dupilumab reverses persistent airflow obstruction among patients with asthma - Healio

Retrieved on: 2023-01-10 22:26:39

Tags for this article:

Click the tags to see associated articles and topics

Dupilumab reverses persistent airflow obstruction among patients with asthma - Healio. View article details on hiswai:

Excerpt

Disclosures: The study was sponsored by Sanofi and Regeneron Pharmaceuticals. Hanania reports receiving research support from AstraZeneca, Boehringer ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up